Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_4
1
20%
Ph early_phase_1
3
60%
Ph not_applicable
1
20%

Phase Distribution

3

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
3(60.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Other(2)

Detailed Status

Not yet recruiting3
unknown2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (60.0%)
Phase 41 (20.0%)
N/A1 (20.0%)

Trials by Status

not_yet_recruiting360%
unknown240%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
DRUG
Total Trials
5